The organophosphorus insecticides have been known for many years to cause cholinergic crisis in humans as a result of the inhibition of the critical enzyme acetylcholinesterase. The interactions of the activated, toxic insecticide metabolites (termed oxons) with acetylcholinesterase have been studied extensively for decades. However, more recent studies have suggested that the interactions of certain anticholinesterase organophosphates with acetylcholinesterase are more complex than previously thought since their inhibitory capacity has been noted to change as a function of inhibitor concentration. In the present report, chlorpyrifos oxon (O,O-diethyl O-(3,5,6-trichloro-2-pyridyl) phosphate) was incubated with human recombinant acetylcholinesterase in the presence of p-nitrophenyl acetate in order to better characterize kinetically the interactions of this oxon with enzyme. Determination of the dissociation constant, K d , and the phophorylation rate constant, k 2 , for chlorpyrifos oxon with a range of oxon and p-nitrophenyl acetate concentrations revealed that K d , but not k 2 , changed as a function of oxon concentration. Changes in p-nitrophenyl acetate concentrations did not alter these same kinetic parameters. The inhibitory capacity of chlorpyrifos oxon, as measured by k i (k 2 /K d ), was also affected as a result of the concentration-dependent alterations in binding affinity. These results suggest that the concentration-dependent interactions of chlorpyrifos oxon with acetylcholinesterase resulted from a different mechanism than the concentration-dependent interactions of acetylthiocholine. In the latter case, substrate bound to the peripheral anionic site of acetylcholinesterase has been shown to reduce enzyme activity by blocking the release of the product thiocholine from the active site gorge. With chlorpyrifos oxon, the rate of release of 3,5,6-trichloro-2-pyridinol is irrelevant since the active site is not available to interact with other oxon molecules after phosphorylation of Ser-203 has occurred.
Organophosphorus insecticides such as chlorpyrifos (O, 5, phosphorothioate) are known to cause cholinergic crisis in humans as a result of the inhibition of the critical enzyme acetylcholinesterase [EC 3.1.1.7] (Mileson et al., 1998) . The inhibition of this important enzyme by the activated metabolites (called oxygen analogs or oxons) of organophosphorus insecticides has been studied extensively and occurs through phophorylation of Ser-203 of the catalytic triad (numbers refer to the amino acid position of human acetylcholinesterase) (Aldridge and Reiner, 1972; Kryger et al., 2000; Ordentlich et al., 1996; Shafferman et al., 1992) . However, the interactions of chlorpyrifos oxon (O,O-diethyl O-(3,5,6 -trichloro-2-pyridyl) phosphate) ( Fig. 1) , as well as certain other oxons, with acetylcholinesterase have been shown to be more complex than was originally thought. Kinetic evidence has suggested that chlorpyrifos oxon likely reversibly binds to a secondary site that subsequently influences events at the active site (Kaushik et al., 2007) . This conclusion was reached because, as the concentration of chlorpyrifos oxon increased, the capacity of individual chlorpyrifos oxon molecules to inhibit acetylcholinesterase was reduced (Kaushik et al., 2007) . Therefore, the original kinetic scheme developed to describe phophorylation of acetylcholinesterase by oxons of organophosphorus insecticides (upper panel in Fig. 2) proved to be inadequate in describing the interactions of acetylcholinesterase with a wide range of concentrations of chlorpyrifos oxon. A more accurate description of these interactions was supplied by the kinetic scheme in the lower panel of Figure 2 , which includes a secondary, regulatory binding site (Kaushik et al., 2007) .
Concentration-dependent inhibition of acetylcholinesterase by chlorpyrifos oxon could result from changes in binding affinity (K d ) or changes in the rate of the phosphorylation reaction (k 2 ). Kaushik et al. (2007) attempted to address this issue by utilizing a technique that involves coincubation of the surrogate substrate acetylthiocholine with chlorpyrifos oxon and acetylcholinesterase in order to determine these kinetic constants at different chlorpyrifos oxon concentrations. Not surprisingly, however, it was observed that acetylthiocholine also altered the inhibitory capacity of chlorpyrifos oxon, probably due to its ability to bind to the peripheral anionic site of acetylcholinestersae in addition to the active site (Kaushik et al., 2007) . The current report revisits this question by employing the test substrate p-nitrophenyl acetate (Fig. 1) , which, to date, appears to follow simple Michaelis Menten kinetics and appears not to bind to any secondary site on acetylcholinesterase.
MATERIALS AND METHODS
Chemicals. Chlorpyrifos oxon was purchased from Chem Services (West Chester, PA.). Human recombinant acetylcholinesterase, bovine serum albumin, p-nitrophenyl acetate, p-nitrophenol, and all other chemicals were purchased from Sigma Chemical Company (St Louis, MO).
Determination of K d , k 2 , and k i for chlorpyrifos oxon. The K d (k -1 /k 1 ) and k 2 were determined by the zero-time method (Gray and Duggleby, 1989; Hart and O'Brien, 1973) , as described by Kaushik et al. (2007) . This approach allows the determination of these two important kinetic constants by monitoring the hydrolysis of a test substrate ( p-nitrophenyl acetate in the current report) in the absence and presence of a single concentration of inhibitor (chlorpyrifos oxon). Hydrolysis of p-nitrophenyl acetate hydrolysis was monitored at 37°in a Shimadzu UV-2550 spectrophotometer (Shimadzu Scientific Instruments, Inc., Columbia, MD) set to a wavelength of 405 nm to quantify p-nitrophenol production. p-Nitrophenyl acetate has been shown to decompose spontaneously in water and is known to be further hydrolyzed slowly by bovine serum albumin (Means and Bender, 1975; Sakurai et al., 2004) , which was present in the buffer in order to stabilize human recombinant acetylcholinesterase. These activities had to be monitored and subtracted from total activity in order to determine acetylcholinesterase-catalyzed hydrolysis. Additionally, p-nitrophenol acetate stock solutions were made up in ethanol for stability and were the last ingredient added (in a volume of 10 ll) to the preheated cuvette to initiate the reaction. The total volume of the incubation within the cuvette was 1.5 ml. The active site concentrations of acetylcholinesterase within the cuvettes were determined as previously described (Rosenfeld and Sultatos, 2006) and ranged from 65 to 70pM.
Briefly, the p-nitrophenol produced from p-nitrophenyl acetate with time was fitted to the following equation:
where [P] and [P] N represent the product concentrations ( p-nitrophenol) at any time t and at t ¼ N, respectively, and the constant A represents the apparent rate constant for the formation of inhibited enzyme (Gray and Duggleby, 1989; Liu and Tsou, 1986) . The initial velocities of incubations containing inhibitor were determined after cubic spline analyses of the fitted curves from Equation 1, as previously described (Barak et al., 1995; Kaushik et al., 2007) . The K d was calculated from:
where v c is the control velocity (in the absence of inhibitor) and v 0 is the initial velocity in the presence of inhibitor, obtained through cubic spline analyses. The constant k 2 was determined from the following equation:
as described by Kaushik et al. (2007) . In Equation 3, D(ln v )/t represents the slope obtained from the semilogarithmic plot of the changing slopes of the product formation curves in the presence of inhibitor (obtained through cubic spline analyses) versus t, and where
The K m for p-nitrophenyl acetate hydrolysis by acetylcholinesterase was determined by monitoring metabolism over a range of p-nitrophenyl acetate concentrations. The K m and V max were calculated by fitting the data to the Michaelis Menten equation.
The k i for chlorpyrifos oxon was calculated from the following equation:
Modeling. In order to investigate the possible limitations of the zero-time method, hydrolysis of a wide range of p-nitrophenyl acetate concentrations by acetylcholinesterase in the presence of various chlorpyrifos oxon concentrations was modeled according to the kinetic scheme shown in the upper panel of Figure 2 . This model is referred to as the zero-time model, and the equations that formed it were as follows:
Kinetic schemes descriptive of the interactions of p-nitrophenyl acetate and chlorpyrifos oxon with human recombinant acetylcholinesterase. The upper panel contains schemes based on simple Michaelis Menten kinetics, which form the basis for the zero-time model. Within the upper panel, AB represents p-nitrophenyl acetate; E designates free enzyme; EAB represents p-nitrophenyl acetate reversibly bound to enzyme; B signifies p-nitrophenol; EA represents acetylated enzyme; and A represents acetate. Similarly, CD represents chlorpyrifos oxon; ECD represents chlorpyrifos oxon reversibly bound to enzyme active site; D designates 3,5,6-trichloro-2-pyridinol; EC signifies phosphorylated enzyme; and C represents diethyl phosphate. Aging is not included because of the short duration of the incubations (300 s). The lower panel contains a more complex kinetic scheme for the interactions of chlorpyrifos oxon with enzyme, where the inhibitor also binds reversibly to a secondary site, thereby altering the events at the active site. In this panel, CD-E represents chlorpyrifos oxon bound reversibly to this putative secondary site; CD-ECD designates enzyme with reversibly bound chlorpyrifos oxon at both the active site and a putative secondary site; and CD-EC represents enzyme phosphorylated at the active site, with chlorpyrifos oxon bound reversibly to a putative secondary site. All other symbols have the same meaning as in the upper panel. 
CHLORPYRIFOS OXON AND ACETYLCHOLINESTERASE
In these equations, E T represents the initial free acetylcholinesterase active site concentration; AB T is the initial p-nitrophenyl acetate concentration; and CD T signifies the initial chlorpyrifos oxon concentration. All other parameters used in Equations 6-14 have the same meaning as indicated in Figure 2 . Following the generation of simulated p-nitrophenol production from p-nitrophenyl acetate in the presence of chlorpyrifos oxon, the K d and k 2 for chlorpyrifos oxon were determined for the simulated data as described above for experimental data. The k 2 for p-nitrophenyl acetate (Fig. 2) was calculated from the following relationship (Boyd et al., 2000) :
where
The k 3 in Equation 15 for p-nitrophenyl acetate is equivalent to that of acetylcholine and was set at 1.4 3 10 4 /s (Szegletes et al., 1998) .
Statistical analyses and modeling. All statistical analyses and curvefitting procedures were conducted with Sigmastat and Sigmaplot (SPSS Science Inc., Chicago, IL). The model simulations represented by Equations 6-14 were solved on a laptop or desktop computer using ACSL 11.8 (Advanced Continuous Simulation Language, Aegis, Huntsville, AL).
RESULTS
Previous investigators have documented that recombinant acetylcholinesterase is unstable in solution unless in the presence of certain 'stabilizers' such as bovine serum albumin (EstradaMondaca and Fournier, 1998; Shafferman et al., 1992) . In the current report, bovine serum albumin was utilized to stabilize human recombinant acetylcholinesterase, thereby necessitating the evaluation of p-nitrophenyl acetate hydrolysis by this protein. Incubation of various concentrations of bovine serum albumin in buffer in the absence of acetylcholinesterase led to the hydrolysis of p-nitrophenyl acetate (Fig. 3) , as previously noted (Means and Bender, 1975; Sakurai et al., 2004) . Activity has been reported to result from the acetylation of certain tyrosine residues, and the deviation from linearity seen at the higher bovine serum albumin concentrations (Fig. 3) likely resulted from the acetylation of different tyrosines at different rates (Means and Bender, 1975 ). In the current study, all subsequent incubations contained bovine serum albumin at a concentration of 0.1 mg/ml, which resulted in limited nonspecific breakdown of p-nitrophenyl acetate (Fig. 3) . Nevertheless, activity was great enough to warrant careful quantification and subtraction from the total hydrolytic activity measured in all subsequent incubations.
With the zero-time method, calculation of K d and k 2 for an organophosphate inhibitor requires knowledge of the K m for the substrate included within the incubation (Gray and Duggleby, 1989; Hart and O'Brien, 1973) . Incubation of concentrations of p-nitrophenyl acetate from 0.5 to 8.75mM with acetylcholinesterase allowed the determination of the K m and V max for the hydrolysis of this substrate by this enzyme (Fig. 4) . Substrate inhibition, which would be expected if p-nitrophenyl acetate were bound to the peripheral anionic site on acetylcholinesterase, was not seen (Fig. 4) . 
SULTATOS
Incubation of increasing concentrations of chlorpyrifos oxon with p-nitrophenyl acetate and human recombinant acetylcholinesterase resulted in progressive inhibition of p-nitrophenol production (Fig. 5) . Analyses of the metabolic profiles (upper panel in Fig. 5 ) and the secondary plots (lower panel in Fig. 5 ) by the zero-time method yielded estimates of K d and k 2 for chloryrifos oxon at a variety of inhibitor concentrations (Fig. 6) . Those K d s determined with chlorpyrifos oxon concentrations from 6.25 to 50nM were not significantly different from one another, whereas the K d determined with 3.125nM chlorpyrifos oxon was reduced by about one-half (Fig. 6) . Unfortunately, chlorpyrifos oxon concentrations lower than 3.125nM did not result in enough inhibition to consistently yield initial velocities less than the velocity of control incubations (without chlorpyrifos oxon; data not shown). Additionally, no evidence of activation of p-nitrophenyl acetate hydrolysis was seen, in contrast to that observed with acetylthiocholine hydrolysis (Kaushik et al., 2007) . No significant differences were observed with chlorpyrifos oxon k 2 s (data not shown) which had an overall mean and standard deviation of 229.27/h þ 56.03. Calculation of chlorpyrifos oxon k i s (by Equation 5) at the various oxon concentrations revealed that the k i remained unchanged until 3.125nM chlorpyrifos oxon, at which point it increased, reflecting the decrease in K d at this same concentration (Fig. 6) .
The values for the parameters contained within the zero-time model are shown in Table 1 . Certain parameters were taken from the literature (Table 1) , while values for others (k 1A , k 10A , k 1C , k 10C , and k 2c ) (Fig. 2) , were selected to give a simulated metabolic profile similar in nature, but not identical, to that of the empirical data (Figs. 5 and 7) . It must be noted, however, that the zero-time model was not intended to accurately simulate the empirical data but instead was developed as a tool to rigorously investigate the possible limitations of this methodology. This evaluation was accomplished by constructing a model based on selected values for the K d and k 2 of chlorpyrifos oxon (Table 1) . Simulations were performed over a range of p-nitrophenyl acetate and chlorpyrifos oxon concentrations, with K d and k 2 calculated from the output for each simulation. The validity of the zero-time method was tested by comparing the calculated values for K d and k 2 with the selected values used in the zero-time model.
The zero-time model simulated hydrolysis of p-nitrophenyl acetate in the absence and presence of chlorpyrifos oxon and yielded metabolic profiles characteristic of those observed with empirical data (Figs. 5 and 7) . Simulated substrate hydrolysis was reduced as chlorpyrifos oxon concentrations were increased (Fig. 7) . Calculation of the K d and k 2 of chlorpyrifos oxon from the simulations over a range of p-nitrophenyl acetate and chloryprifos oxon concentrations yielded accurate values for these kinetic constants, until the p-nitrophenyl acetate concentration exceeded the K m for this substrate, at which point the K d and k 2 were underestimated (Fig. 8) . Surprisingly, chlorpyrifos oxon concentrations three times greater than the model's selected inhibitor K d (50nM) gave accurate K d 's and k 2 's, provided the p-nitrophenyl acetate levels were equal to or lower than this substrate's K m (Fig. 8) .
DISCUSSION
Previous studies have reported that the inhibitory capacity of chlorpyrifos oxon changes as a function of the chlorpyrifos oxon concentration (Kaushik et al., 2007; Kousba et al., 2004) . Kinetic evidence has suggested the existence of a secondary binding site for this organophosphate, although such a binding (Equation 5). Kaushik et al. (2007) attempted to determine whether K d and/or k 2 changed as a function of chlorpyrifos oxon concentration using the zerotime method but found that the use of acetylthiocholine as the test substrate introduced confounding factors since this substrate itself altered chlorpyrifos oxon inhibitory kinetics. Conversely, no evidence has been reported that would suggest that the substrate p-nitrophenyl acetate binds to any site on acetylcholinesterase other than the active site, and the kinetic analyses performed in the current study supports a simple Michaelis Menten kinetic model for this substrate (Fig. 4) . However, use of p-nitrophenyl acetate was complicated by its spontaneous decomposition as well as breakdown mediated by bovine serum albumin (Fig. 3) . The smallest concentration of bovine serum albumin that stabilized the human recombinant acetylcholinesterase (0.1 mg/ml), was used, and bovine serum albumin mediated breakdown as well as spontaneous decomposition was carefully quantified and accounted for in each experiment.
The original zero-time method developed by Hart and O'Brien (1973) was proposed for use when the test substrate ( p-nitrophenyl acetate) and organophosphate inhibitor concentrations were well below their K d 's. The computer modeling studies in the current report established that this assumption could be violated without rendering the zero-time method inacurrate since the highest inhibitor concentration was three times greater than its K d (Fig. 8) . Interestingly, the p-nitrophenyl acetate concentration could equal its K d , but not be higher (Fig. 8) . These simulations indicate that the zero-time method is far more robust than originally thought by Hart and O'Brien (1973) for p-nitrophenyl acetate.
The zero-time method established that the binding affinity of chlorpyrifos oxon appeared to increase as the concentration of this inhibitor was reduced to 3.125nM, thereby accounting, at least in part, for the concentration-dependent alteration in its k i previously reported (Kaushik et al., 2007; Kousba et al., 2004) . Stated differently, the binding affinity of chlorpyrifos oxon, as measured by its K d , was decreased as the oxon concentration exceeded 3.125nM (Fig. 6) . The lack of an effect of oxon concentration on k 2 is not surprising since Ordentlich et al. (1996) have shown, by site-directed mutagenesis, that the nucleophilic attack of Ser-203 on the phosphorus atom of certain organophosphate inhibitors is not very sensitive to changes in the architecture of the active site. Instead, the 132 SULTATOS phosphorylation reaction is dependent primarily on the nucleophilicity of Ser-203 and the electronic properties of the phosphoryl moiety (Kemp and Wallace, 1990; Ordentlich et al., 1996) .
While it is tempting to make analogies between concentration-dependent kinetics of chlorpyrifos oxon and the concentration-dependent kinetics of acetylcholine or acetylthiocholine, the mechanisms for these two phenomena are likely quite different. Kinetic studies (Johnson et al., 2003; Mallender et al., 2000; Szegletes et al., 1999) , and crystallography (Bourne et al., 2006; Colletier et al., 2006) have documented that the substrate inhibition observed with acetylthiocholine likely results from steric blockade of the release of thiocholine. A molecule of acetylthiocholine bound to the peripheral anionic site seems to prevent the release of thiocholine produced from a second acetylthiocholine molecule at the active site. This mechanism cannot account for the concentration-dependent kinetics observed with chlorpyrifos oxon since phosphorylation of Ser-203 by the oxon yields an intermediate that does not reactivate during the time course of the experiments in the current report. Consequently, whether or (Barak et al., 1995) . The slopes and intercepts of the lines in the lower panel were determined by linear regression analyses and were used in Equations 2 and 3 to determine the K d and k 2 of chlorpyrifos oxon in these simulations. CHLORPYRIFOS OXON AND ACETYLCHOLINESTERASE 133 not 3,5,6-trichloro-2-pyridinol release was blocked is irrelevant since the phosphorylated Ser-203 was not available to interact with another chlorpyrifos oxon molecule. Instead, the results of the current report are better explained by hypothesizing the existence of a binding site on acetylcholinesterase for chlorpyrifos oxon that allosterically affects the active site gorge in a manner that decreases the binding affinity of other chlorpyrifos oxon molecules. The active site gorge of acetylcholinesterase has been shown to contain regions that help position substrate as well as organophosphate inhibitors to form Michaelis complexes (Ordentlich et al., 1996 (Ordentlich et al., , 1998 (Ordentlich et al., , 2004 Soreq and Seidman, 2001) . A region identified as the acyl pocket (Phe-295 and Phe-297) has been implicated in the positioning of certain organophosphates for nucleophilic attack by Ser-203, while the region known as the oxyanion hole subsite (Gly-121, Gly-122, and Ala-204) has been proposed to polarize the P¼O bond, thereby activating the phosphorus and promoting the nucleophilic attack (Ordentlich et al., 1996 (Ordentlich et al., , 1998 . Allosteric modification that would change position of an important residue in either of these regions could result in a decreased binding affinity for inhibitor. One possible secondary binding site is the peripheral anionic site, and De Ferrari et al. (2001) and Shi et al. (2001) have documented conformational interactions between the peripheral anionic site and different regions of the active site gorge. Additionally, Bourne et al. (2006) have identified possible substrate binding sites on the surface of acetylcholinesterase located distal to the active site gorge. These authors speculated that occupation of these putative sites could allosterically affect substrate binding and catalytic parameters (Bourne et al., 2006) .
A change in binding affinity, and therefore inhibitory capacity, of an organophosphate as a function of the concentration of that inhibitor, indicates that a linear relationship between organophosphate concentration and acetylcholinesterase activity does not exist when a broad range of organophosphate concentrations are considered. Since the inhibitory capacity of chlorpyrifos oxon toward human acetylcholinesterase has been shown to decrease as a function of concentration with inhibitor levels up to about 10nM (Kaushik et al., 2007) , dose-response curves generated from chlorpyrifos oxon concentrations higher than about 10nM likely underestimate the risk represented by lower oxon levels.
